WO1996005189A1 - Nouveaux inhibiteurs de type benzamidine - Google Patents
Nouveaux inhibiteurs de type benzamidine Download PDFInfo
- Publication number
- WO1996005189A1 WO1996005189A1 PCT/CH1995/000174 CH9500174W WO9605189A1 WO 1996005189 A1 WO1996005189 A1 WO 1996005189A1 CH 9500174 W CH9500174 W CH 9500174W WO 9605189 A1 WO9605189 A1 WO 9605189A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carbon atoms
- radical
- straight
- thrombin
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/974—Thrombin
Definitions
- the invention relates to new thrombin inhibitors of the amidinophenylalanine type, their preparation and their use for combating diseases. They are distinguished in particular by the fact that they carry a substituted piperazine residue in different positions of the molecule.
- trypsin-like serine proteinases such enzymes are of particular physiological importance that trigger coagulation and fibrinolysis in the blood. Since the pathologically increased activity of the enzymes or the lack of natural inhibitors can lead to diseases, attempts are made to control these diseases by increasing the inhibitor potential. Accordingly, natural inhibitors - endogenous to the body such as antithrombin III or those from other natural sources such as hirudin - are used or prepared for the therapy.
- inhibitors of the coagulation enzymes are being worked on particularly intensively. Extensive biochemical and (animal) experimental pharmacological studies have shown that inhibitors of throbine in particular are effective anticoagulants and antithrombotics.
- the present invention relates to new thrombin inhibitors having a benzidine structure of the general formulas I and II
- R 1 in the general formula I is a straight-chain alkylsulfonyl radical having 1 to 16 carbon atoms, preferably 6 to 10 carbon atoms
- R * 2 is a straight-chain Alkylsulfonyl radical having 1 to 8 carbon atoms
- R ⁇ in the general formula II is a straight-chain alkylsulfonyl radical having 1 to 4 carbon atoms, an alkanoyl radical having 1 to 4 carbon atoms and n is an integer of 1 or 2.
- the inhibitor derivatives of the general formulas I and II according to the invention can be treated with a mineral acid, e.g. HC1, HBr, H2SO4 or H3PO4, or with an organic acid, e.g. Formic, acetic, oxalic or tartaric acid may be protonized.
- a mineral acid e.g. HC1, HBr, H2SO4 or H3PO4
- an organic acid e.g. Formic, acetic, oxalic or tartaric acid may be protonized.
- the compounds of the general formula I are prepared by the known production process described below.
- amidine derivatives of the formula I are prepared from these cyanphenylalanine derivatives obtained by known processes (via thioamide, thioimido ester or imido ester route).
- the amidino derivatives of the general formula II are built up in stages in accordance with the production process known per se and described below.
- (D) -4-cyanophenylalanine is first N-acylated with an acid-labile protective group and then the ⁇ (carboxyl group is converted to a piperidide. After the o-amino protective group has been cleaved off, the (D) - -4-cyanophenylalanine piperidide is also converted a No ⁇ - -2-naphthylsulfonyl derivative of the formula IV,
- R ⁇ is an acid labile carboxyl protecting group, e.g. t-butyl, and n represents the number 1 or 2, implemented.
- the compounds according to the invention can be used per se or - in combination with carriers and auxiliaries - as medicaments, and they can be administered subcutaneously, intravenously, but especially orally or rectally.
- carriers and auxiliaries - as medicaments
- they can be administered subcutaneously, intravenously, but especially orally or rectally.
- the compounds according to the invention can be used in particular in test kits for determining thrombin.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne de nouveaux inhibiteurs de thrombine de type amidinophénylalanine. Les composés sont résorbables notamment par voie rectale et par voie orale.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU31077/95A AU3107795A (en) | 1994-08-09 | 1995-08-09 | Inhibitors of the benzamidine type |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH2469/94-9 | 1994-08-09 | ||
CH246994 | 1994-08-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996005189A1 true WO1996005189A1 (fr) | 1996-02-22 |
Family
ID=4234519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CH1995/000174 WO1996005189A1 (fr) | 1994-08-09 | 1995-08-09 | Nouveaux inhibiteurs de type benzamidine |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3107795A (fr) |
WO (1) | WO1996005189A1 (fr) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997029104A1 (fr) * | 1996-02-05 | 1997-08-14 | Zeneca Limited | Composes aminoheterocycliques produisant un effet antithrombotique et anticoagulant |
WO1998054164A1 (fr) * | 1997-05-30 | 1998-12-03 | Takeda Chemical Industries, Ltd. | Derives de la sulfonamide, leur production et leurs utilisations |
WO1999064392A1 (fr) * | 1998-06-08 | 1999-12-16 | Ajinomoto Co., Inc. | Derive de benzamidine |
WO2000004954A2 (fr) * | 1998-07-20 | 2000-02-03 | Wilex Biotechnology Gmbh | Nouveaux inhibiteurs d'urokinase |
EP1016663A1 (fr) * | 1999-01-02 | 2000-07-05 | Aventis Pharma Deutschland GmbH | Dérivés de l'acide malonique, procédé pour leur préparation, leur utilisation comme médicaments et compositions les contenant (inhibiteurs du facteur Xa ) |
WO2000040571A1 (fr) * | 1999-01-02 | 2000-07-13 | Aventis Pharma Deutschland Gmbh | Nouveaux derives d'acide malonique, procedes de preparation de ces derives, leur utilisation et compositions pharmaceutiques les contenant (inhibition de l'activite du facteur xa) |
US6093718A (en) * | 1996-08-14 | 2000-07-25 | Zeneca Limited | Substituted pyrimidine derivatives and their pharmaceutical use |
US6225309B1 (en) | 1994-09-26 | 2001-05-01 | Zeneca Limited | Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
EP1127884A1 (fr) * | 2000-02-26 | 2001-08-29 | Aventis Pharma Deutschland GmbH | Dérivés de l'acide malonique, procédés pour leur préparation, leur utilisation comme inhibiteur du facteur XA et compositions les contenants |
US6300330B1 (en) | 1996-11-08 | 2001-10-09 | Zeneca Limited | Heterocycle derivatives which inhibit factor Xa |
US6313127B1 (en) | 1996-02-02 | 2001-11-06 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
US6391880B1 (en) | 1997-02-13 | 2002-05-21 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
US6440972B1 (en) | 1997-02-13 | 2002-08-27 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
WO2002074756A2 (fr) * | 2001-03-21 | 2002-09-26 | Pentapharm Ag | Inhibiteurs d'urokinase |
US6486154B1 (en) | 1997-07-29 | 2002-11-26 | Zeneca Limited | (Hetero) aryl-sulfonamide derivatives, their preparation and their use as factor XA inhibitors |
US6538017B2 (en) | 2001-03-09 | 2003-03-25 | Ortho-Mcneil Pharmaceutical, Inc. | Aminopyrrolidine sulfonamides as serine protease inhibitors |
US6680312B2 (en) | 1998-02-05 | 2004-01-20 | Takeda Chemical Industries, Ltd. | Sulfonamide derivatives, their production and use |
US6710061B2 (en) | 2001-03-09 | 2004-03-23 | Ortho-Mcneil Pharamceutical, Inc. | Aminopyrrolidine sulfonamides as serine protease inhibitors |
US6723723B1 (en) | 1999-02-11 | 2004-04-20 | Astrazeneca | Heterocyclic derivatives as inhibitors of factor Xa |
US7342018B2 (en) | 1998-07-20 | 2008-03-11 | Wilex Ag | Urokinase inhibitors and uses thereof |
WO2022175136A2 (fr) | 2021-02-16 | 2022-08-25 | Dsm Ip Assets B.V. | Nouveaux inhibiteurs de lrat |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2007663A (en) * | 1977-11-07 | 1979-05-23 | Dresden Arzneimittel | Sulphonylated omega - amidinophenyl- alpha -aminocarhoxylic acid amides |
DD155954A1 (de) * | 1981-02-03 | 1982-07-21 | Wagner Guenter | Verfahren zur herstellung von n tief alpha aryl-bzw.n tief alpha heteroarylsulfonylaminoacylierten amidinophenylalaninamiden |
EP0097630A2 (fr) * | 1982-06-23 | 1984-01-04 | KabiVitrum AB | Dérivés de N-alpha-arylsulfonyl-p-guanidino-phénylalanine utiles comme inhibiteur de la thrombine |
DD235866A1 (de) * | 1985-03-29 | 1986-05-21 | Univ Leipzig | Verfahren zur herstellung von n alpha -sulfonylaminoacylierten amidinophenylalaninamiden |
DD242404A1 (de) * | 1985-11-04 | 1987-01-28 | Univ Leipzig | Verfahren zur herstellung n alpha-sulfonylaminoacylierter 3-amidino-phenylalaninester |
EP0236164A1 (fr) * | 1986-01-24 | 1987-09-09 | Sanofi | Dérivés des N alpha-arylsulfonylaminoacyl p-amidino-phénylalaninamides, leur procédé de préparation, leur application comme médicaments et leurs intermédiaires de synthèse |
EP0236163A1 (fr) * | 1986-01-24 | 1987-09-09 | Sanofi | Dérivés N alpha-substitués des N alpha-arylsulfonylaminoacyl p-amidinophénylalaninamides, leur préparation, leur application comme médicaments et intermédiaires pour leur synthèse |
WO1992008709A1 (fr) * | 1990-11-15 | 1992-05-29 | Pentapharm Ag | Derives de la phenylalanine metasubstitues |
EP0508220A1 (fr) * | 1991-04-09 | 1992-10-14 | BEHRINGWERKE Aktiengesellschaft | Dérivées d'amidino-phenylalanine, procédé de leur préparation, leur utilisation et composition les contenants |
-
1995
- 1995-08-09 AU AU31077/95A patent/AU3107795A/en not_active Abandoned
- 1995-08-09 WO PCT/CH1995/000174 patent/WO1996005189A1/fr active Application Filing
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2007663A (en) * | 1977-11-07 | 1979-05-23 | Dresden Arzneimittel | Sulphonylated omega - amidinophenyl- alpha -aminocarhoxylic acid amides |
DD155954A1 (de) * | 1981-02-03 | 1982-07-21 | Wagner Guenter | Verfahren zur herstellung von n tief alpha aryl-bzw.n tief alpha heteroarylsulfonylaminoacylierten amidinophenylalaninamiden |
EP0097630A2 (fr) * | 1982-06-23 | 1984-01-04 | KabiVitrum AB | Dérivés de N-alpha-arylsulfonyl-p-guanidino-phénylalanine utiles comme inhibiteur de la thrombine |
DD235866A1 (de) * | 1985-03-29 | 1986-05-21 | Univ Leipzig | Verfahren zur herstellung von n alpha -sulfonylaminoacylierten amidinophenylalaninamiden |
DD242404A1 (de) * | 1985-11-04 | 1987-01-28 | Univ Leipzig | Verfahren zur herstellung n alpha-sulfonylaminoacylierter 3-amidino-phenylalaninester |
EP0236164A1 (fr) * | 1986-01-24 | 1987-09-09 | Sanofi | Dérivés des N alpha-arylsulfonylaminoacyl p-amidino-phénylalaninamides, leur procédé de préparation, leur application comme médicaments et leurs intermédiaires de synthèse |
EP0236163A1 (fr) * | 1986-01-24 | 1987-09-09 | Sanofi | Dérivés N alpha-substitués des N alpha-arylsulfonylaminoacyl p-amidinophénylalaninamides, leur préparation, leur application comme médicaments et intermédiaires pour leur synthèse |
WO1992008709A1 (fr) * | 1990-11-15 | 1992-05-29 | Pentapharm Ag | Derives de la phenylalanine metasubstitues |
EP0508220A1 (fr) * | 1991-04-09 | 1992-10-14 | BEHRINGWERKE Aktiengesellschaft | Dérivées d'amidino-phenylalanine, procédé de leur préparation, leur utilisation et composition les contenants |
DE4111394A1 (de) * | 1991-04-09 | 1992-10-15 | Behringwerke Ag | Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel |
Non-Patent Citations (3)
Title |
---|
CHEMICAL ABSTRACTS, vol. 107, no. 5, 3 August 1987, Columbus, Ohio, US; abstract no. 40333v, page 758; column L; * |
CHEMICAL ABSTRACTS, vol. 108, no. 11, 14 March 1988, Columbus, Ohio, US; abstract no. 94939m, page 702; column L; * |
CHEMICAL ABSTRACTS, vol. 98, no. 13, 28 March 1983, Columbus, Ohio, US; abstract no. 107770b, page 645; column L; * |
Cited By (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6225309B1 (en) | 1994-09-26 | 2001-05-01 | Zeneca Limited | Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
US6730672B2 (en) | 1994-09-26 | 2004-05-04 | Zeneca Limited | Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
US6313127B1 (en) | 1996-02-02 | 2001-11-06 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
US6022869A (en) * | 1996-02-05 | 2000-02-08 | Zeneca Limited | Aminoheterocyclic compounds with antithrombotic/anticoagulant effect |
WO1997029104A1 (fr) * | 1996-02-05 | 1997-08-14 | Zeneca Limited | Composes aminoheterocycliques produisant un effet antithrombotique et anticoagulant |
US6093718A (en) * | 1996-08-14 | 2000-07-25 | Zeneca Limited | Substituted pyrimidine derivatives and their pharmaceutical use |
US6936610B2 (en) | 1996-11-08 | 2005-08-30 | Astrazeneca Uk Limited | Heterocyclic derivatives |
US6300330B1 (en) | 1996-11-08 | 2001-10-09 | Zeneca Limited | Heterocycle derivatives which inhibit factor Xa |
US6440972B1 (en) | 1997-02-13 | 2002-08-27 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
US6391880B1 (en) | 1997-02-13 | 2002-05-21 | Zeneca Limited | Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
WO1998054164A1 (fr) * | 1997-05-30 | 1998-12-03 | Takeda Chemical Industries, Ltd. | Derives de la sulfonamide, leur production et leurs utilisations |
US6359134B1 (en) | 1997-05-30 | 2002-03-19 | Takeda Chemical Industries, Ltd. | Sulfonamide derivatives, their production and use |
US6486154B1 (en) | 1997-07-29 | 2002-11-26 | Zeneca Limited | (Hetero) aryl-sulfonamide derivatives, their preparation and their use as factor XA inhibitors |
US6680312B2 (en) | 1998-02-05 | 2004-01-20 | Takeda Chemical Industries, Ltd. | Sulfonamide derivatives, their production and use |
US6410538B2 (en) | 1998-06-08 | 2002-06-25 | Ajinomoto Co., Inc. | Benzamidine derivatives |
WO1999064392A1 (fr) * | 1998-06-08 | 1999-12-16 | Ajinomoto Co., Inc. | Derive de benzamidine |
EP1264828A1 (fr) * | 1998-07-20 | 2002-12-11 | Wilex AG | Nouveau inhibiteur d'urokinase |
WO2000004954A3 (fr) * | 1998-07-20 | 2000-06-22 | Wilex Biotechnology Gmbh | Nouveaux inhibiteurs d'urokinase |
JP2002521348A (ja) * | 1998-07-20 | 2002-07-16 | ヴィレックス アクチェンゲゼルシャフト | 新規ウロキナーゼインヒビター |
US7342018B2 (en) | 1998-07-20 | 2008-03-11 | Wilex Ag | Urokinase inhibitors and uses thereof |
WO2000004954A2 (fr) * | 1998-07-20 | 2000-02-03 | Wilex Biotechnology Gmbh | Nouveaux inhibiteurs d'urokinase |
US6624169B1 (en) | 1998-07-20 | 2003-09-23 | Wilex Biotechnology Gmbh | Urokinase inhibitors |
US6680320B2 (en) | 1998-07-20 | 2004-01-20 | Wilex Ag | Urokinase inhibitors |
WO2000040571A1 (fr) * | 1999-01-02 | 2000-07-13 | Aventis Pharma Deutschland Gmbh | Nouveaux derives d'acide malonique, procedes de preparation de ces derives, leur utilisation et compositions pharmaceutiques les contenant (inhibition de l'activite du facteur xa) |
EP1016663A1 (fr) * | 1999-01-02 | 2000-07-05 | Aventis Pharma Deutschland GmbH | Dérivés de l'acide malonique, procédé pour leur préparation, leur utilisation comme médicaments et compositions les contenant (inhibiteurs du facteur Xa ) |
US6395737B1 (en) | 1999-01-02 | 2002-05-28 | Aventis Pharma Deutschland Gmbh | Malonic acid derivatives, processes for their preparation, for their use and pharmaceutical compositions containing them |
US6723723B1 (en) | 1999-02-11 | 2004-04-20 | Astrazeneca | Heterocyclic derivatives as inhibitors of factor Xa |
EP1127884A1 (fr) * | 2000-02-26 | 2001-08-29 | Aventis Pharma Deutschland GmbH | Dérivés de l'acide malonique, procédés pour leur préparation, leur utilisation comme inhibiteur du facteur XA et compositions les contenants |
WO2001062735A1 (fr) * | 2000-02-26 | 2001-08-30 | Aventis Pharma Deutschland Gmbh | Nouveaux derives d'acide malonique, procedes de preparation de ceux-ci, leur utilisation comme inhibiteur de l'activite du facteur xa et compositions pharmaceutiques les contenant |
US6794365B2 (en) | 2000-02-26 | 2004-09-21 | Aventis Pharma Deutschland Gmbh | Malonic acid derivatives, processes for their preparation their use and pharmaceutical compositions containing them |
US6630505B2 (en) | 2001-03-09 | 2003-10-07 | Ortho-Mcneil Pharmaceutical, Inc. | Aminopyrrolidine sulfonamides as serine protease inhibitors |
US6710061B2 (en) | 2001-03-09 | 2004-03-23 | Ortho-Mcneil Pharamceutical, Inc. | Aminopyrrolidine sulfonamides as serine protease inhibitors |
US6538017B2 (en) | 2001-03-09 | 2003-03-25 | Ortho-Mcneil Pharmaceutical, Inc. | Aminopyrrolidine sulfonamides as serine protease inhibitors |
US6890939B2 (en) | 2001-03-09 | 2005-05-10 | Ortho-Mcneil Pharmaceutical, Inc. | Aminopyrrolidine sulfonamides as serine protease inhibitors |
US6861435B2 (en) | 2001-03-21 | 2005-03-01 | Pentapharm Ag | Urokinase inhibitors |
WO2002074756A3 (fr) * | 2001-03-21 | 2002-12-12 | Pentapharm Ag | Inhibiteurs d'urokinase |
WO2002074756A2 (fr) * | 2001-03-21 | 2002-09-26 | Pentapharm Ag | Inhibiteurs d'urokinase |
WO2022175136A2 (fr) | 2021-02-16 | 2022-08-25 | Dsm Ip Assets B.V. | Nouveaux inhibiteurs de lrat |
WO2022175136A3 (fr) * | 2021-02-16 | 2022-09-29 | Dsm Ip Assets B.V. | Nouveaux inhibiteurs de lrat |
Also Published As
Publication number | Publication date |
---|---|
AU3107795A (en) | 1996-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996005189A1 (fr) | Nouveaux inhibiteurs de type benzamidine | |
DE2438350C3 (de) | Peptide mit starker LH-RH/FSH-RH-Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
EP0513543B1 (fr) | Dérivés d'amidino-phenylalanine, procédé de leur préparation, leur utilisation et compositions anticoagulantes les contenant | |
EP0511347A1 (fr) | Derives de la phenylalanine metasubstitues | |
EP0635008A1 (fr) | Piperazides de derives substitues de phenylalanine utilises comme inhibiteurs de la thrombine | |
EP1294742B1 (fr) | Inhibiteurs de l'urokinase | |
CH634039A5 (de) | Somatostatinanalogon, sowie verfahren zu seiner herstellung. | |
EP1114024B1 (fr) | Inhibiteurs de l'urokinase | |
EP1267854B1 (fr) | Inhibiteurs a selectivite elevee de l'activateur de type urokinase du plasminogene | |
EP0508220B1 (fr) | Dérivées d'amidino-phenylalanine, procédé de leur préparation, leur utilisation et composition les contenants | |
CH636847A5 (de) | Verfahren zur herstellung von neuen verbindungen, die eine peptidstruktur besitzen. | |
CA1251898A (fr) | Peptides pharmaceutiques, preparation et application | |
DE2256445A1 (de) | Neue heptapeptide mit gastrinwirkung | |
DE60133654T2 (de) | Arzneimittel enthaltend analgetische peptide | |
DE2438352A1 (de) | Peptidcyclopropylamide mit lh-rh/fshrh-wirkung | |
CH615904A5 (en) | Process for the preparation of L-leucine-13-motilin | |
DE2740699C2 (fr) | ||
DE2730549A1 (de) | Peptidderivate und deren herstellung | |
CH649562A5 (de) | Derivate des methionin-enzephalins. | |
JPS58109460A (ja) | エンケフアリン誘導体 | |
DE1543872C3 (de) | D Ser hoch 1 Nie hoch 4 Pentacosapeptid sowie Verfahren zu dessen Herstellung | |
US4405607A (en) | Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use | |
DE2718718A1 (de) | Somatostatinanaloge und zwischenprodukte hierzu | |
CH689611A5 (de) | Urokinase-Inhibitoren. | |
DE3782006T2 (de) | Peptide. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |